Found: 13
Select item for more details and to access through your institution.
The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells.
- Published in:
- Cell Biochemistry & Biophysics, 2022, v. 80, n. 4, p. 819, doi. 10.1007/s12013-022-01100-5
- By:
- Publication type:
- Article
The Role of Substance P in Neurodegenerative Diseases.
- Published in:
- Acta Medica Iranica, 2020, v. 58, n. 7, p. 301
- By:
- Publication type:
- Article
The Emerging Role of Neurokinin-1 Receptor Blockade Using Aprepitant in the Redox System of Esophageal Squamous Cell Carcinoma.
- Published in:
- International Journal of Peptide Research & Therapeutics, 2022, v. 28, n. 3, p. 1, doi. 10.1007/s10989-022-10399-w
- By:
- Publication type:
- Article
Recent advances in the clinical development of immune checkpoint blockade therapy.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 5, p. 609, doi. 10.1007/s13402-019-00456-w
- By:
- Publication type:
- Article
Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-κB Signal Transduction Pathways in Colon Cancer Cells.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/1383878
- By:
- Publication type:
- Article
Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-κB Signal Transduction Pathways in Colon Cancer Cells.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/1383878
- By:
- Publication type:
- Article
The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.
- Published in:
- Molecular Biology Reports, 2022, v. 49, n. 10, p. 9307, doi. 10.1007/s11033-022-07771-w
- By:
- Publication type:
- Article
Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
- Published in:
- Molecular Biology Reports, 2020, v. 47, n. 5, p. 3469, doi. 10.1007/s11033-020-05432-4
- By:
- Publication type:
- Article
Role of tumor microenvironment in the regulation of PD‐L1: A novel role in resistance to cancer immunotherapy.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 10, p. 6496, doi. 10.1002/jcp.29671
- By:
- Publication type:
- Article
Cytokines as potential combination agents with PD‐1/PD‐L1 blockade for cancer treatment.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 7/8, p. 5449, doi. 10.1002/jcp.29491
- By:
- Publication type:
- Article
Effect of folic acid‐linked chitosan‐coated PLGA‐based curcumin nanoparticles on the redox system of glioblastoma cancer cells.
- Published in:
- Phytochemical Analysis, 2023, v. 34, n. 8, p. 950, doi. 10.1002/pca.3263
- By:
- Publication type:
- Article
The thioredoxin system and cancer therapy: a review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The effect of SP/NK1R on expression and activity of glutaredoxin and thioredoxin proteins in prostate cancer cells.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, v. 397, n. 8, p. 5875, doi. 10.1007/s00210-024-02996-x
- By:
- Publication type:
- Article